Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vomaris Innovations
AddedFeb 15, 2024
UpdatedJun 18, 2026
Vomaris Innovations

Vomaris Innovations

Vomaris Innovations: Advancing wound care through microcurrent field technology.

HQ
Tempe, AZ, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Vomaris Innovations, founded with a mission to revolutionize wound care, focuses on developing advanced microcurrent field generating technologies. Their core product, Procellera®, now available over-the-counter as PowerHeal™ Antibacterial Bioelectric Bandages, utilizes unique V.DOX® Technology to reduce infection risks and support wound healing. Vomaris targets the global wound care market, addressing critical issues like biofilm infections that hinder healing and resist antibiotics.

Notable figures associated with Vomaris Innovations include experts in medical device technology and wound care. The company has secured investments from key players in the healthcare sector, underscoring its innovative approach. Vomaris has achieved significant milestones, including the successful commercialization of its products on platforms like Amazon. Its impact is evident in the enhanced healing outcomes and reduced infection rates for patients worldwide, positioning Vomaris as a leader in bioelectric wound care solutions.

Vomaris Innovations - Similar Companies

Vaporox logo

Vaporox

Biofisica logo

Biofisica

biofisica.com

Medtric logo

Medtric

medtricbiotech.com

O2 RegenTech logo

O2 RegenTech

Vohra Wound Physicians logo

Vohra Wound Physicians

vohrawoundcare.com

MDM Wound Ventures logo

MDM Wound Ventures

ezdebride.com

Wound Care Technologies logo

Wound Care Technologies

SweetBio logo

SweetBio

sweetbio.com

Amnio Technology logo

Amnio Technology

BioNova logo

BioNova

bionovamedical.com

Somavac Medical Solutions logo

Somavac Medical Solutions

somavac.com

Portal Instruments logo

Portal Instruments

WoundZoom logo

WoundZoom

perceptivesol.com

MLM Biologics logo

MLM Biologics

mlmbiologics.com

ProVazo logo

ProVazo

Vomaris Innovations - Quick Facts

Who are Vomaris Innovations' competitors?

Companies similar to Vomaris Innovations include Vaporox, Biofisica, Medtric and O2 RegenTech.

When was Vomaris Innovations founded?

Vomaris Innovations was founded in 2004.

Where is Vomaris Innovations' headquarters located?

Vomaris Innovations' headquarters is located in Tempe, AZ, US.

When was Vomaris Innovations' last funding round?

Vomaris Innovations' most recent funding round was for $1.5M (USD) in October 2018.

How much has Vomaris Innovations raised to-date?

As of Oct 24, 2018, Vomaris Innovations has raised a total of $17.7M (USD).

How many employees does Vomaris Innovations have?

Vomaris Innovations has 16 employees as of Feb 5, 2024.

Vomaris Innovations - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Bandages
  • Wound Care
Tags
  • Healthtech
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified